<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778280</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-02-17</org_study_id>
    <nct_id>NCT04778280</nct_id>
  </id_info>
  <brief_title>Vitamin D Estimation With Giardia Lamblia Infections</brief_title>
  <official_title>Estimation of Vitamin D in Humans Infected With Giardia Lamblia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      investigators will take stool and blood samples from two groups of humans :-&#xD;
&#xD;
      1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or&#xD;
      case group)then investigators make estimation for vitamin D in both groups then investigators&#xD;
      try to find if there is relation between vitamin D level and Giardia lamblia infections&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this research a case- control study will be used) ,the percentage of case to control will&#xD;
      be 1:1 the total number of samples 192 ,investigators will take stool and blood samples from&#xD;
      two groups of humans :-&#xD;
&#xD;
      1-group A (healthy group negative Giardia or control group),2-group B (positive Giardia or&#xD;
      case group)then investigators make estimation for vitamin D in both groups then investigators&#xD;
      try to find if there is relation between vitamin D level and Giardia lamblia infections&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fluctuation level of vitamin D level</measure>
    <time_frame>1 year</time_frame>
    <description>Estimation of vitamin D level in humans infected with Giardia lamblia</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Giardia Lamblia Infection</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <description>1-Group A(Healty group with negative Giardia lamblia or control group) 96 samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <description>2- Group B(Cases group with positive Giardia lamblia )96 sample</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        we take 192 samples then we will divide these samples into two groups :-&#xD;
&#xD;
          1. Group A (healty group with negative Giardia lamblia or control group)&#xD;
&#xD;
          2. Group B ( diseased group with positive Giardia lamblia or cases group)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient infected with Giardia lamblia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient takes vitamin D supplement - patient has kidney disease- patient has liver&#xD;
             disease-patient has a debilitating disease disease such as cancer or diabetes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed Sayed Farrag, Demonstrator</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of medicine sohag university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammed Sayed Farrag, Demonstrator</last_name>
    <role>Study Director</role>
    <affiliation>faculty of medicine sohag university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammed Sayed Farrag, Demonstrator</last_name>
    <phone>01110054887</phone>
    <email>mohameds_post@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Noha Sammer Ahmed, Assist prof</last_name>
    <phone>01273126001</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine Sohag University</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed Sayed Farrag, Demonstrator</last_name>
      <phone>01110054887</phone>
      <email>mohameds_post@med.sohag.edu.eg</email>
    </contact>
    <investigator>
      <last_name>Mohammed Sayed Farrag, Demonstrator</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammed sayed farrag, demonstrator</last_name>
      <phone>01110054887</phone>
      <email>mohameds_post@med.sohag.edu.eg</email>
    </contact>
    <contact_backup>
      <last_name>Noha sammer ahmed, assist prof</last_name>
      <phone>01273126001</phone>
    </contact_backup>
    <investigator>
      <last_name>Mohammed sayed farrag, demonstrator</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 25, 2021</study_first_submitted>
  <study_first_submitted_qc>February 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 27, 2021</last_update_submitted>
  <last_update_submitted_qc>February 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Mohamed Sayed Farrag</investigator_full_name>
    <investigator_title>principlal investigator</investigator_title>
  </responsible_party>
  <keyword>estimaion of vitamin D in humans infected with Giardia lamblia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Giardiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

